Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasunori Funayama

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|April 2, 2009
Chemotherapy for Langerhans cell sarcomaGen Ohara, Yasunori Funayama, Hiroaki Satoh, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 12, 2020
Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organismsYoshihiko Kiyasu, Shigemi Hitomi, Yasunori Funayama, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 2, 2013
Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilisYoko Kurihara, Shigemi Hitomi, Tsuyoshi Oishi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 24, 2015
High-level aminoglycoside resistance in Enterococcus faecalis and Enterococcus faecium causing invasive infection: Twelve-year surveillance in the Minami Ibaraki AreaHanako Osuka, Jun Nakajima, Tsuyoshi Oishi, et al.
Journal of Microorganism Control|June 16, 2024
Clinical and Microbiological Characteristics of Bacteremia Caused by Carbapenemase-producing Enterobacterales in Minami Ibaraki Area, JapanMichie Uchida, Norihiko Terada, Kazuhito Saito, et al.
Medical Oncology (Northwood, London, England)|November 1, 2008
A population-based study of gefitinib in patients with non-small cell lung cancerKenji Hayashibara, Hiroaki Satoh, Yoko Shinohara, et al.
Anticancer Research|April 30, 2022
Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for <i>EGFR</i>-mutated Non-small Cell Lung CancerToshihiro Shiozawa, Takeshi Numata, Tomohiro Tamura, et al.
In Vivo (Athens, Greece)|July 2, 2020
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant MetastasisTakeshi Numata, Takeo Endo, Hidetoshi Yanai, et al.
Emerging Infectious Diseases|June 12, 2013
Mycobacterium kyorinense infectionHiroaki Ohnishi, Shota Yonetani, Satsuki Matsushima, et al.
In Vivo (Athens, Greece)|July 2, 2020
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer PatientsKunihiko Miyazaki, Shinya Sato, Takahide Kodama, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|April 2, 2009
Chemotherapy for Langerhans cell sarcomaGen Ohara, Yasunori Funayama, Hiroaki Satoh, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 12, 2020
Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organismsYoshihiko Kiyasu, Shigemi Hitomi, Yasunori Funayama, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 2, 2013
Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilisYoko Kurihara, Shigemi Hitomi, Tsuyoshi Oishi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 24, 2015
High-level aminoglycoside resistance in Enterococcus faecalis and Enterococcus faecium causing invasive infection: Twelve-year surveillance in the Minami Ibaraki AreaHanako Osuka, Jun Nakajima, Tsuyoshi Oishi, et al.
Journal of Microorganism Control|June 16, 2024
Clinical and Microbiological Characteristics of Bacteremia Caused by Carbapenemase-producing Enterobacterales in Minami Ibaraki Area, JapanMichie Uchida, Norihiko Terada, Kazuhito Saito, et al.
Medical Oncology (Northwood, London, England)|November 1, 2008
A population-based study of gefitinib in patients with non-small cell lung cancerKenji Hayashibara, Hiroaki Satoh, Yoko Shinohara, et al.
Anticancer Research|April 30, 2022
Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for <i>EGFR</i>-mutated Non-small Cell Lung CancerToshihiro Shiozawa, Takeshi Numata, Tomohiro Tamura, et al.
In Vivo (Athens, Greece)|July 2, 2020
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant MetastasisTakeshi Numata, Takeo Endo, Hidetoshi Yanai, et al.
Emerging Infectious Diseases|June 12, 2013
Mycobacterium kyorinense infectionHiroaki Ohnishi, Shota Yonetani, Satsuki Matsushima, et al.
In Vivo (Athens, Greece)|July 2, 2020
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer PatientsKunihiko Miyazaki, Shinya Sato, Takahide Kodama, et al.
Pageof 2